Cut-Off Values for Gait and Balance in MS
Determination of Cut-Off Values for Gait Variability and Balance Scores in Patients With Multiple Sclerosis
1 other identifier
observational
65
1 country
1
Brief Summary
Purpose of the Study: The aim of this study is to determine the cut-off values of gait variability and limits of stability-postural sways scores in patients with MS in order to identify fall risk at an early stage and take necessary precautions. Additionally, the study aims to compare the effectiveness of these parameters in distinguishing between fallers and non-fallers. The study includes four hypotheses: H₁: Gait variability scores can differentiate between fallers and non-fallers in patients with MS. H₂: Limits of stability and postural sways scores can differentiate between fallers and non-fallers in patients with MS. H₃: Gait variability scores provide higher sensitivity and specificity than stability limits and postural sway scores in distinguishing between fallers and non-fallers in patients with MS. H₄: Limits of stability and postural sways scores provide higher sensitivity and specificity than gait variability scores in distinguishing between fallers and non-fallers in patients with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2025
CompletedFirst Submitted
Initial submission to the registry
August 6, 2025
CompletedFirst Posted
Study publicly available on registry
September 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedMay 22, 2026
May 1, 2026
6 months
August 6, 2025
May 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Limits of Stability
Limits of stability assessment will be conducted using the Bertec Balance Check Screener™ force platform system (45×45 cm, 13 cm thick), which detects body movements via foot pressure.Limits of stability will be measured by asking participants to lean maximally in four directions (forward, backward, right, left) without losing balance. Stability scores (in cm and %) will be calculated using Balance Check Software.
up to 5 months
Postural sways
Postural sways assessment will be conducted using the Bertec Balance Check Screener™ force platform system (45×45 cm, 13 cm thick), which detects body movements via foot pressure. A foam pad of the same size is used to assess postural sway. Postural sways will be evaluated under four conditions (eyes open/closed on firm/foam surfaces). Participants will stand still for 10 seconds per condition, repeated three times. The average stability score (%) will be recorded for each condition.
up to 5 months
Gait variability
Gait variability will be performed using the GAITRite® system, a 4.6-meter portable walkway mat embedded with pressure sensors that record step data without interfering with the natural gait. Participants will walk naturally across the mat three times; the average of the trials will be analyzed. Gait variability will be expressed as the coefficient of variation (CV) (%). Using this formula: CV (%) = (standard deviation/mean) × 100.
up to 5 months
Fall Histories
The following fall-related information will be recorded: Number of Falls Cause of Fall Time of Fall Activity During Which the Fall Occurred Type of Fall Fall-Related Injury / If Present, Type of Injury
up to 5 months
Study Arms (1)
Multiple Sclerosis
• Patients diagnosed with MS by a neurologist according to the McDonald criteria, aged 18 years or older, having an EDSS score of ≤ 5 (able to walk independently), and having a Mini-Mental State Examination score of 24 or higher will be included in the study.
Eligibility Criteria
MS patients with the inclusion criteria
You may qualify if:
- Diagnosed with MS by a neurologist according to the McDonald criteria
- Aged 18 years or older
- EDSS ≤ 5 (able to walk independently)
- Mini-Mental State Examination score of 24 or higher
You may not qualify if:
- Patients with neurological conditions other than MS that may affect independent walking or standing, those with lower extremity pain, or a history of lower extremity fractures within the past 6 months
- Patients who do not agree to participate or do not provide written informed consent will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Altındağ, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammed Kılınç
Hacettepe University
- PRINCIPAL INVESTIGATOR
Ender Ayvat
Hacettepe University
- STUDY DIRECTOR
Fatma Ayvat
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 6, 2025
First Posted
September 3, 2025
Study Start
July 17, 2025
Primary Completion
January 6, 2026
Study Completion
January 31, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05